Carl Walkey's Insider Trades & SAST Disclosures
Carl Walkey's most recent trade in Neoleukin Therapeutics Inc was a trade of 150,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 2, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Carl Walkey.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 55,000 | 55,000 | - | - | Restricted Stock Units | |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 10.19 per share. | 16 Jun 2021 | 600 | 1,352,489 (2%) | 0% | 10.2 | 6,114 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 10.82 per share. | 09 Jun 2021 | 650 | 1,353,089 (2%) | 0% | 10.8 | 7,036 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 08 Jun 2021 | 600 | 1,353,739 (2%) | 0% | 11 | 6,600 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 04 Jun 2021 | 600 | 1,354,339 (2%) | 0% | 10 | 6,000 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 26 May 2021 | 600 | 1,354,939 (2%) | 0% | 10 | 6,000 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 10.63 per share. | 19 May 2021 | 600 | 1,355,539 (2%) | 0% | 10.6 | 6,378 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 11.09 per share. | 12 May 2021 | 1,200 | 1,354,762 (2%) | 0% | 11.1 | 13,308 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 11.30 per share. | 05 May 2021 | 1,200 | 1,355,962 (2%) | 0% | 11.3 | 13,560 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 12.58 per share. | 28 Apr 2021 | 2,400 | 1,357,162 (2%) | 0% | 12.6 | 30,192 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 26 Apr 2021 | 600 | 1,359,562 (2%) | 0% | 13 | 7,800 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 11.98 per share. | 21 Apr 2021 | 1,800 | 1,360,162 (2%) | 0% | 12.0 | 21,564 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 12.22 per share. | 14 Apr 2021 | 1,800 | 1,361,962 (2%) | 0% | 12.2 | 21,996 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 12.02 per share. | 07 Apr 2021 | 1,800 | 1,363,762 (2%) | 0% | 12.0 | 21,636 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 05 Apr 2021 | 600 | 1,365,562 (2%) | 0% | 13 | 7,800 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 11.96 per share. | 31 Mar 2021 | 1,800 | 1,366,162 (2%) | 0% | 12.0 | 21,528 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 11.95 per share. | 22 Mar 2021 | 1,800 | 1,367,962 (2%) | 0% | 12.0 | 21,516 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 22 Mar 2021 | 600 | 1,369,762 (2%) | 0% | 12 | 7,200 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 11.36 per share. | 17 Mar 2021 | 1,200 | 1,370,362 (2%) | 0% | 11.4 | 13,632 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 11.97 per share. | 10 Mar 2021 | 1,800 | 1,371,562 (2%) | 0% | 12.0 | 21,540 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 11.87 per share. | 03 Mar 2021 | 1,800 | 1,373,362 (2%) | 0% | 11.9 | 21,360 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 12.14 per share. | 24 Feb 2021 | 1,800 | 1,375,762 (2%) | 0% | 12.1 | 21,852 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 24 Feb 2021 | 600 | 1,375,162 (2%) | 0% | 13 | 7,800 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 12.70 per share. | 17 Feb 2021 | 2,400 | 1,377,562 (2%) | 0% | 12.7 | 30,480 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 14.20 per share. | 10 Feb 2021 | 3,000 | 1,379,962 (2%) | 0% | 14.2 | 42,600 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 05 Feb 2021 | 600 | 1,382,962 (2%) | 0% | 14 | 8,400 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Sale of securities on an exchange or to another person at price $ 13.23 per share. | 03 Feb 2021 | 2,400 | 1,383,562 (2%) | 0% | 13.2 | 31,752 | Common Stock |
| Neoleukin Therapeutics Inc | Carl Walkey | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2021 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges